OpenBilldrug price receipt

NADAC week of 2026-10-14

MOXIFLOXACIN HCL 400 MG TABLET

For 30 tablets

Pharmacies pay

$40.12 filed

30 × $1.33723 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$117.71 filed

30 × $3.92378 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

2.9× estimated

Medicare paid 2.9× what pharmacies pay.

Part D averages every strength and form sold under “Moxifloxacin HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$51.14 estimated

$40.12 + $6.02 (15%) + $5.00 fee per fill = $51.14

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

MOXIFLOXACIN HCL 400 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “moxifloxacin hydrochloride” and “moxifloxacin hydrochloride tablets, 400 mg”, as its NDCs’ listings variously write the nonproprietary name, under the trade name “Moxifloxacin”.

FDA gives its dosage form as tablet, film coated and its route as oral.

FDA lists 7 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, AvPAK and Rising Pharma Holdings, Inc.

FDA lists it under 2 Established Pharmacologic Classes: Fluoroquinolone Antibacterial and Quinolone Antimicrobial.

The NADAC file of 2026-10-14 prices it under 11 NDCs (National Drug Codes); the FDA directory lists 8 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $40.12 for 30 tablets (30 × $1.33723 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 7 labelers

LabelerNDCsPharmacies pay per unit
Major Pharmaceuticals2$1.33723 per EA filed
American Health Packaging1$1.33723 per EA filed
Aurobindo Pharma Limited1$1.33723 per EA filed
AvPAK1$1.33723 per EA filed
Novadoz Pharmaceuticals LLC1$1.33723 per EA filed
Rising Pharma Holdings, Inc.1$1.33723 per EA filed
Solaris Pharma Corporation1$1.33723 per EA filed
Not listed as a package in the FDA directory3$1.33723 per EA filed
All 11 NDCs, with labeler and price
  • 00093-7387-56 · not listed as a package in the FDA directory · $1.33723 per EA · eff. 2026-09-23 filed
  • 00904-7407-04 · Major Pharmaceuticals · $1.33723 per EA · eff. 2026-09-23 filed
  • 00904-7407-06 · Major Pharmaceuticals · $1.33723 per EA · eff. 2026-09-23 filed
  • 50268-0576-11 · not listed as a package in the FDA directory · $1.33723 per EA · eff. 2026-09-23 filed
  • 50268-0576-13 · AvPAK · $1.33723 per EA · eff. 2026-09-23 filed
  • 57237-0156-30 · Rising Pharma Holdings, Inc. · $1.33723 per EA · eff. 2026-09-23 filed
  • 65862-0603-30 · Aurobindo Pharma Limited · $1.33723 per EA · eff. 2026-09-23 filed
  • 68084-0722-11 · not listed as a package in the FDA directory · $1.33723 per EA · eff. 2026-09-23 filed
  • 68084-0722-65 · American Health Packaging · $1.33723 per EA · eff. 2026-09-23 filed
  • 72205-0001-30 · Novadoz Pharmaceuticals LLC · $1.33723 per EA · eff. 2026-09-23 filed
  • 73473-0903-30 · Solaris Pharma Corporation · $1.33723 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

2 other products in the NADAC file share an FDA nonproprietary name with MOXIFLOXACIN HCL 400 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
MOXIFLOXACIN 0.5% EYE DROPS
generic · solution/ drops / solution
$1.59631 per ML filed
eff. 2026-09-23
We don’t know yet
MOXIFLOXACIN HCL 400 MG TABLET this page
generic · tablet, film coated
$1.33723 per EA filed
eff. 2026-09-23
$3.92378 per EA filed
Part D 2024 average
VIGAMOX 0.5% EYE DROPS
brand · solution/ drops
$31.808 per ML filed
eff. 2026-06-17
$60.70401 per ML filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-06-17, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 11 NDCs’ NADAC prices is $1.33723 per EA filed.

Of the 4 other products in FDA’s Fluoroquinolone Antibacterial class priced per EA, 1 has a higher middle NADAC price and 3 a lower one. The one in the middle is CIPROFLOXACIN HCL 500 MG TAB, at $0.12284 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $117.71 for 30 tablets, at an average of $3.92378 per EA in 2024 (2024-01-01 to 2024-12-31) for “Moxifloxacin HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 64,055 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

10 of the product’s 11 NDCs have this Medicare figure; the other 1 do not, and the interactive card says why for each.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for MOXIFLOXACIN HCL 400 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Moxifloxacin HCl / Moxifloxacin HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.